טוען...
NUMBER NEEDED TO TREAT TO BENEFIT AND TO HARM FOR IV TPA THERAPY IN THE 3-4.5 HOUR WINDOW: JOINT OUTCOME TABLE ANALYSIS OF THE ECASS 3 TRIAL
BACKGROUND: Measures of a therapy’s effect size are important guides to clinicians, patients, and policy-makers on treatment decisions in clinical practice. The ECASS 3 trial demonstrated a statistically significant benefit of intravenous TPA for acute cerebral ischemia in the 3–4.5 hour window, but...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2724988/ https://ncbi.nlm.nih.gov/pubmed/19498197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.108.543561 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|